Company Filing History:
Years Active: 2005-2012
Title: Inventor Per Lindquist - Pioneering Advances in Neurobiology
Introduction
Per Lindquist, a distinguished inventor based in Bromma, Sweden, has made significant contributions to the field of neurobiology. With a total of three patents to his name, Lindquist is recognized for his innovative approaches to treating central nervous system (CNS) disorders. His work continues to pave the way for new therapeutic strategies that hold promise for patients suffering from various neurological conditions.
Latest Patents
One of Per Lindquist's latest patents focuses on the "Modulation of Neural Stem Cells and Neural Progenitor Cells." This invention relates to methods that influence CNS cells, promoting the production of progeny that are beneficial for treating CNS disorders. Specifically, it outlines techniques for exposing patients with such disorders to a reagent that modulates the proliferation, migration, differentiation, and survival of CNS cells through S1P or LPA signaling. These advanced methods are designed to reduce at least one symptom of the disorder, representing a significant milestone in neurotherapeutics.
Career Highlights
Per Lindquist works at Neuronova AB, a company dedicated to innovative solutions in the neuroscience sector. His contributions to the company and the scientific community demonstrate his commitment to advancing understanding and treatment options for CNS disorders. With his expertise, Lindquist has become a valuable asset in the field, influencing both research and practical applications.
Collaborations
Within Neuronova AB, Per collaborates with esteemed colleagues such as Alex Mercer and Harriet Rönnholm. Together, they work towards innovative solutions that leverage cutting-edge research to address complex neurological challenges. Their teamwork and diverse skill sets contribute greatly to the company's mission and success in developing groundbreaking therapies.
Conclusion
In summary, Per Lindquist stands out as a remarkable inventor whose work is shaping the future of neurobiology. His latest patents, particularly those related to the modulation of neural stem cells, highlight the potential for significant advancements in treating CNS disorders. Through his continued dedication and collaborative efforts at Neuronova AB, Lindquist is poised to make lasting impacts on both medical science and patient care.